XML 46 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 8,493,000 $ 4,175,000
Adjustments to reconcile net income to net cash provided from operating activities:    
Depreciation and amortization 2,842,000 1,620,000
Provision for bad debts - accounts receivable 141,000 86,000
Share-based compensation expense 1,338,000 789,000
Deferred income tax provision (benefit) 130,000 (584,000)
Gain on sales of property, plant and equipment (91,000) (12,000)
Accretion of acquisition-related contingent liability 96,000  
Changes in assets and liabilities, net of acquisition of business:    
Accounts receivable - trade (7,091,000) (4,134,000)
Accounts receivable - other 530,000 (201,000)
Inventories (5,958,000) 1,498,000
Prepaid expenses and other current assets 608,000 (58,000)
Other assets 14,000 (165,000)
Accounts payable 2,918,000 2,308,000
Other current liabilities 91,000 3,875,000
Pension liability 68,000 485,000
Other long-term liabilities (65,000) (133,000)
Net cash provided from operating activities 4,064,000 9,549,000
CASH FLOWS FROM INVESTING ACTIVITIES    
Additions to property, plant and equipment (4,334,000) (1,122,000)
Disposals of property, plant and equipment 128,000 14,000
Purchase of business   (32,483,000)
Net cash used in investing activities (4,206,000) (33,591,000)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt 46,197,000 44,740,000
Repayment of long-term debt (47,322,000) (17,990,000)
Payment of cash dividends (2,675,000)  
Proceeds received on exercise of stock options 1,461,000 319,000
Excess tax benefit from exercise of stock options 188,000  
Common stock reacquired and retired   (162,000)
Net cash (used in) provided from financing activities (2,151,000) 26,907,000
Net (decrease) increase in cash and cash equivalents (2,293,000) 2,865,000
Cash and cash equivalents balance, beginning of year 5,316,000 3,554,000
Cash and cash equivalents balance, end of period $ 3,023,000 $ 6,419,000